Understanding Clinical Trials
Understanding
Clinical Trials (National Cancer Institute)
Provides general and in-depth information on clinical trials and related
topics. Includes A
Guide to Understanding Informed Consent.
Cancer Trials Help:
Are Clinical Trials Right for You? (Coalition of National
Cancer Cooperative Groups)
Offers a comprehensive view of clinical trials, including: Clinical Trials
ABCs, questions to ask your doctor, an overview of the cooperative group
system, a list of trials conducted by members of the Coalition of National
Cancer Cooperative Groups, and a glossary, among other resources.
Don't
Be Afraid of Clinical Trials: They Could Improve the Quality of Care You
Receive (Cancer Care)
Discusses the medical, practical and emotional issues involved in clinical
trial participation.
Evaluating
a Clinical Trial (Onconurse.com)
Guide to evaluating a clinical trial. Explains how to examine the inclusion
and exclusion criteria, the informed consent document, and the protocol
document. Provides a list of questions that you should ask before entering
a clinical trial. Offers perspectives from patients who have previously
participated in clinical trials. [2001]
Finding Clinical Trials
*** It is important to note that no single clinical trials resource
provides a comprehensive listing of all available trials for lung cancer.
***
Clinical Trials
(National Cancer Institute)
NCI's clinical trials database and information center. Includes information
on understanding clinical trials; deciding whether to participate in clinical
trials; and finding
specific trials in the NCI's PDQ clinical trials database.
ClinicalTrials.gov
(National Institutes of Health)
Clinical trials database developed by the National Library of Medicine.
Trials database may be searched by keyword or browsed by condition, such
as lung
cancer. The "Understanding Clinical Trials" section offers comprehensive
information on all aspects of clinical trials.
Clinical
Trials: Oncology (Centerwatch)
Listing of cancer clinical trials by therapeutic area and geographic region.
Areas include lung cancer, cancer pain, and bone metastases.
Centerwatch
Patient Notification Service
Free e-mail clinical trials notification service. User can specify particular
therapeutic area, e.g. lung cancer, and be notified via e-mail of new
trial postings.
Pharmaceutical Companies
(Lung Cancer Online)
Listing of pharmaceutical companies that offer products used in the treatment
of lung cancer. Product information often includes links and/or information
related to clinical trials.
Lung Cancer Programs
(Lung Cancer Online)
Directory of NCI-Designated Cancer Centers and other hospitals with
lung cancer programs. Links to specific resources, including clinical
trials, are included where information is available.
Clinical Trial Insurance Issues
Clinical
Trials and Insurance Coverage: A Resource Guide (National
Cancer Institute)
Answers frequently-asked questions about insurance coverage for clinical
trial participation and provides links to additional information resources.
Sections include: clinical trials and insurance coverage; coverage strategies
to consider; initiatives to expand coverage for clinical trials. [1/02]
Compassionate Use Information
Compassionate
Use Offers Access to Unapproved Drugs (CURE)
by Jennifer M. Gangloff
v.3, no.3 CURE (Fall 2004): 72-3
Patient article discusses the various ways patients to get experimental
or investigational drugs if they are not able to enroll in a clinical
trial, but lack effective treatment, including: expanded access programs
(EAP) and single patient use. Provides tips for successfully pursuing
compassionate use options. Briefly discusses the option of looking outside
the US if compassionate use is not available. [10/04]
Understanding
the Approval Process for New Cancer Drug: Special Needs
(National Cancer Institute)
Discusses special conditions in which cancer drugs that have not
yet been through the FDA approval process. Provides links to information
explaining the approval process for new cancer drugs, "off-label" use
and expanded access. [1/04]
Access to
Unapproved Drugs (Center for Drug Evaluation & Research,
FDA)
Discusses the various legal mechanisms for gaining access to unapproved
drugs, including clinical trials, a special exception or compassionate
exemption, an emergency Investigational New Drug (IND) and a treatment
IND. [10/03]
|
